Long-term immune-related adverse events under PD-1 inhibitors: a multicenter prospective cohort study (MELBASE).

Charlée Nardin,Stéphane Dalle,Marie Thérèse Leccia,Laurent Mortier,S. Dalac-Rat,Caroline Dutriaux,Delphine Legoupil,Henri Montaudie,Olivier Dereure,Julie de Quatrebarbes,Florence Granel-Brocard,Myrtille Le-Bouar,Julie Charles,F. Brunet-Possenti,Brigitte Dreno,Wendy Lefevre,Clara Allayous,Celeste Lebbe,François Aubin

Long-term immune-related adverse events under PD-1 inhibitors: a multicenter prospective cohort study (MELBASE).

2020

Charlée Nardin
Stéphane Dalle
Marie Thérèse Leccia
Laurent Mortier
S. Dalac-Rat
Caroline Dutriaux
Delphine Legoupil
Henri Montaudie
Olivier Dereure
Julie de Quatrebarbes
Florence Granel-Brocard
Myrtille Le-Bouar
Julie Charles
F. Brunet-Possenti
Brigitte Dreno
Wendy Lefevre
Clara Allayous
Celeste Lebbe
François Aubin

10057Background: PD-1 inhibitors (anti-PD1) are frequently associated with immune-related adverse events (IRAE). Since melanoma patients included in clinical trials were frequently treated during t...

Keywords:

Physical therapy
Immune system
Internal medicine
Prospective cohort study
Adverse effect
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations